Reduced risk of severe COVID-19 with lithium use: a large-scale comparison with valproate users and other COVID-19 patients
These findings suggest that lithium may provide a protective effect against severe COVID-19 outcomes, independent of underlying vulnerability, and support further investigation into the broader health implications of psychotropic medications.
Authors
- Uri Blasbalg (ORCID: https://orcid.org/0000-0002-4779-371X)
- Paz Toren
- Chen Avni
Institutions
- Tel Aviv University (IL)
- Clalit Health Services (IL)
Publication Details
- Journal
- Frontiers in Psychiatry
- Published
- 2026-01-05
- DOI
- https://doi.org/10.3389/fpsyt.2025.1702189
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00